Galal H Elgemeie Selected Research

Thioglycosides

7/2021	Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.
8/2020	Toward Developing Therapies against Corona Virus: Synthesis and Anti-Avian Influenza Virus Activity of Novel Cytosine Thioglycoside Analogues.
3/2018	Design, synthesis, molecular docking and anti-hepatocellular carcinoma evaluation of novel acyclic pyridine thioglycosides.
1/2018	Novel dihydropyridine thioglycosides and their corresponding dehydrogenated forms as potent anti-hepatocellular carcinoma agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Galal H Elgemeie Research Topics

Disease

3	Influenza in Birds (Avian Flu) 01/2022 - 08/2020
3	Hepatocellular Carcinoma (Hepatoma) 03/2018 - 05/2017
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2010
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2010
1	COVID-19 01/2022
1	Pneumonia (Pneumonitis) 10/2020
1	Human Influenza (Influenza) 10/2020
1	Ascites 09/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2003

Drug/Important Bio-Agent (IBA)

4	ThioglycosidesIBA 07/2021 - 01/2018
3	purineIBA 01/2022 - 01/2019
3	pyrimidineIBA 01/2022 - 08/2020
3	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2020
3	pyridineIBA 01/2022 - 01/2018
2	Biological ProductsIBA 01/2022 - 01/2019
1	Pharmaceutical PreparationsIBA 07/2021
1	Sulfadiazine (Sulphadiazine)FDA Link 10/2020
1	Ampicillin (Omnipen)FDA LinkGeneric 10/2020
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2020
1	CytosineIBA 08/2020
1	ChitosanIBA 01/2019
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2018
1	ThymineIBA 05/2017
1	AntimetabolitesIBA 09/2010
1	2-mercaptopurineIBA 01/2003

Therapy/Procedure

1	Therapeutics 08/2020